Why is Thyrocare Tech. falling/rising?

As of 18-Nov, Thyrocare Technologies Ltd is experiencing a price increase, currently at Rs 1,591.45, reflecting a rise of Rs 32.25 or 2.07%. The stock has shown strong performance, being only 1.41% away from its 52-week high of Rs 1,613.9. Today, it outperformed its sector by 3.38% and reached an intraday high of Rs 1,607, indicating positive momentum. The stock has also been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, investor participation has increased, with delivery volume rising by 29.64% compared to the 5-day average. Over the past year, the stock has delivered a return of 61.57%, significantly outperforming the BSE500 index, which has only returned 9.48% in the same period.
In the broader market context, Thyrocare's short-term performance of +14.78% over the past week contrasts sharply with the Sensex's modest gain of +0.96%. This indicates that Thyrocare is not only performing well in isolation but is also gaining traction relative to the overall market. The company's strong fundamentals, including a high return on equity (ROE) of 23.66% and a low debt-to-equity ratio, support its rising stock price. However, there are concerns regarding long-term growth, as net sales have only grown at an annual rate of 12.85% over the last five years, and 85.84% of promoter shares are pledged, which could pose risks in a declining market. Despite these risks, the recent positive financial results and consistent performance over multiple quarters contribute to the stock's upward trajectory.